The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.30
Bid: 92.45
Ask: 92.70
Change: 0.65 (0.71%)
Spread: 0.25 (0.27%)
Open: 90.80
High: 92.70
Low: 90.80
Prev. Close: 91.65
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Investor Q&A

1 Apr 2020 07:00

RNS Number : 3130I
Primary Health Properties PLC
01 April 2020
 

Primary Health Properties PLC

("PHP", "Group" or the "Company")

Q1 2020 Trading Update

Investor Q&A

Primary Health Properties PLC, the UK's leading investor in modern primary healthcare facilities, today publishes a trading update for the period 1 January 2020 to 31 March 2020.

During the Covid-19 pandemic we are actively working with the NHS, HSE and our GP tenants to help them better utilise our properties for deployment in the front line of the current global crisis.

Rental collection

90% of the Group's contracted rental income is either paid directly or indirectly by the UK and Irish governments, with the balance mainly coming from pharmacies co-located at our properties. Rental collection continues to remain robust and as at 31 March 2020 79% of the Q1 FY20 rent (Q4 FY19: 73%) had been received, in-line with the Q1 FY19 collection rate and the balance is expected to be received over the next two weeks.

Financing

As at 31 March 2020 the Group's net debt stood at £1,086.0m (31 December 2019: £1,067.3m) and on a pro-forma basis the Loan to Value ("LTV") ratio was 44.8% (31 December: 44.2%).

After capital commitments the Group has undrawn loan facilities and cash on deposit totalling £341.1m (31 December 2019: £356.6m) providing significant liquidity headroom. Cash on deposit totals £137.0m. In addition, on a pro-forma basis the Group's portfolio would need to fall in value by around £1.0bn or 42% for the LTV covenants in the Group's borrowing arrangements to come under risk of being breached.

Debt metrics

31 March 2020

31 December 2019

Average cost of debt

3.5%

3.5%

Loan to value

44.8%

44.2%

Interest cover

2.8 times

2.7 times

Weighted average debt maturity

6.9 years

7.2 years

Total drawn secured debt

£1,062.5m

£1,060.4m

Total drawn unsecured debt

£150.0m

£150.0m

Total undrawn facilities and cash available to the Group1

£341.1m

£356.6m

Unfettered assets

£41.9m

£32.3m

1 - After deducting capital commitments.

Dividend

On 24 March 2020 the Company declared its second quarterly interim dividend of 1.475p per Ordinary Share which will be paid on 22 May 2020 to shareholders who are on the share register at the close of business on 3 April 2020. The dividend will comprise a Property Income Distribution ("PID") of 1.275p and an ordinary dividend of 0.20p per share. The dividend is equivalent to 5.9p on an annualised basis and represents a 5.4% increase over dividends per share paid in 2019.

The Company intends to maintain its strategy of paying a progressive dividend, in equal quarterly instalments, covered by underlying earnings in each financial year. Further dividend payments are planned to be made in August and November 2020.

Investment and development pipeline

Contracts for the acquisition of two forward funded developments at Llanbradach, South Wales (£2.8m) and Epsom, Surrey (£4.1m) were exchanged in February and March 2020 respectively.

PHP continues to have a strong active pipeline of potential acquisitions both in the UK and Ireland totalling approximately £124.0m including £58.0m in legal due diligence but we will continue to have regard to the current market before committing to these.

Developments

The Group completed the forward funded development at Athy, County Kildare, Ireland in the period, on time and within budget at a net development cost of £11.4m (€12.9m) and has a further seven developments currently on site with a net development cost of £56.0m.

Developments on site:

Asset

Anticipated PC date

Area

(sqm)

Net development cost

Cost to

complete

Ireland

 

 

 

 

Bray, County Wicklow

April 2020

4,822

£19.8m (€22.4m)

£6.5m (€7.4m)

Rialto, Dublin

April 2020

3,232

£11.5m (€13.0m)

£0.9m (€1.0m)

Banagher, County Offaly

Q4 2020

1,628

£4.5m (€5.1m)

£3.2m (€3.6m)

UK

 

 

 

 

Mountain Ash, Wales

Q4 2020

1,253

£4.9m

£3.9m

Eastbourne, East Sussex

Q2 2021

1,976

£8.4m

£6.3m

Llanbradach, Wales

Q1 2021

831

£2.8m

£2.4m

Epsom, Surrey

Q1 2021

667

£4.1m

£3.1m

Total

 

14,409

£56.0m

£26.3m

With the exception of Banagher, closed due to Irish Government guidelines, and Epsom, which has not yet commenced, all development sites in the UK and Ireland remain open and construction continues to progress. The Irish HSE is keen for the sites at Bray and Rialto to be completed as soon as possible and a dispensation has been provided to allow them to remain open and completion is due imminently. The Group will continue to adopt a policy of not undertaking any developments on a speculative basis.

Rental income increases

PHP has continued to enhance and grow the rental income of its existing portfolio with 56 rent reviews settled in the first quarter, increasing rent by £0.4m, with a weighted average annualised increase of 2.4%. In addition, a further five asset management projects have been completed, investing £0.9m to enhance and extend existing assets within PHP's portfolio and a strong pipeline of similar projects is being progressed to further increase rental income and extend unexpired occupational lease terms.

Outlook

The COVID-19 pandemic has highlighted the demands on health systems around the world, not least the NHS in the UK and HSE in Ireland, where the underlying demand for healthcare is increasingly driven by growing and ageing populations. The need for modern, integrated, local primary healthcare facilities is becoming more acute in order to relieve the pressures being placed on hospitals and A&E departments. We anticipate that the crisis will highlight the important role primary healthcare will play in the future provision of health services and the continuing movement of services away from over-burdened hospital settings.

Investor Q&A

In lieu of the Q&A which would have taken place at the 2020 AGM, a pre-registered Q&A session will be held as a separate audiocast at 15.00 BST today, Wednesday 1 April. All shareholders and other interested parties are welcome to join the event.

To take part, please register any questions management by emailing them to php@buchanan.uk.com by 11.00 am today. These will be collated and addressed by the Executive management team during this afternoon's audiocast.

In order to access the audiocast, please dial in shortly before 15.00 via the following details:

Dial in number

UK Toll: 0333 300 0804

UK Toll-Free: 0800 358 9473

PIN: 94041314#

URL for international dial in numbers

http://events.arkadin.com/ev/docs/NE_W2_TF_Events_International_Access_List.pdf 

A recording of the event will be made available for replay at the Company's website www.phpgroup.co.uk

Harry Hyman, Managing Director of Primary Health Properties, commented:

"Despite the uncertainty created around the world by the COVID-19 pandemic, our portfolio of properties stands on the front-line of delivering vital services for the NHS and HSE in the UK and Ireland and we are working closely with our occupiers to help them better utilise our assets during this global time of need.

"Whilst it is too early to understand in full the financial implications of the crisis, we remain in a very strong and robust position, with a well-funded balance sheet and excellent portfolio of assets, which will help underpin our strategy of paying a progressive dividend to shareholders which is fully covered by earnings."

 

For further information contact:

Further details:

 

Harry Hyman

Managing Director

Tel: +44 (0) 20 7451 7050

 

Richard Howell

Finance Director

Tel: +44 (0) 20 7104 5599

 

 

David Rydell / Steph Watson / Tilly Abraham(Buchanan Communications)

Tel: +44 (0) 20 7466 5000 

 

 

 

   

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUAUBRRBUOOAR
Date   Source Headline
29th Jun 20237:00 amRNSNotice of Interim Dividend
20th Jun 20237:00 amRNSNotice of Interim Results
19th Jun 20233:26 pmRNSDirector/PDMR Shareholding
19th Jun 20233:23 pmRNSDirector/PDMR Shareholding
14th Jun 20239:26 amRNSHolding(s) in Company
22nd May 20239:47 amRNSDirector/PDMR Shareholding
15th May 20239:18 amRNSDirector/PDMR Shareholding
26th Apr 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20233:58 pmRNSDirector/PDMR Shareholding
19th Apr 20233:23 pmRNSAGM Statement
19th Apr 20237:00 amRNSQ1 2023 Trading Update
11th Apr 20232:46 pmRNSDirector/PDMR Shareholding
11th Apr 20232:44 pmRNSDirector/PDMR Shareholding
6th Apr 202311:14 amRNSDirector’s & PDMR dealings
31st Mar 20239:20 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSNotice of Interim Dividend
15th Mar 20233:44 pmRNSDirector/PDMR Shareholding
15th Mar 20233:41 pmRNSDirector/PDMR Shareholding
15th Mar 202310:29 amRNSDirector/PDMR Shareholding
15th Mar 20238:39 amRNSAnnual Financial Report
14th Mar 202312:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:23 amRNSHolding(s) in Company
1st Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20238:59 amRNSCompany Secretary Change
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
27th Feb 20234:56 pmRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSPreliminary Results
16th Feb 202311:38 amRNSHolding(s) in Company
8th Feb 202310:07 amRNSHolding(s) in Company
1st Feb 20239:40 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSAcquisition
16th Jan 20237:00 amRNSNotice of Preliminary Results
5th Jan 20237:00 amRNSDividend Declaration
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
15th Dec 20229:56 amEQSProactive Research Analyst Manos Halicioglu looks at Primary Health Properties
12th Dec 20227:00 amRNSSuccession Planning
6th Dec 20223:10 pmRNSHolding(s) in Company
30th Nov 202211:55 amRNSDirector/PDMR Shareholding
25th Nov 20222:19 pmRNSHolding(s) in Company
10th Nov 202210:30 amRNSDirector/PDMR Shareholding
7th Nov 202211:07 amRNSAppointment of joint broker
21st Oct 202212:01 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
20th Oct 20224:39 pmRNSHolding(s) in Company
13th Oct 20225:00 pmRNSConvertible Bond Adjustment
6th Oct 20227:00 amRNSDividend Declaration
27th Sep 20227:00 amRNSValue Creation Award Win
14th Sep 20225:36 pmRNSDirector/PDMR Shareholding
14th Sep 20225:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.